Company news
Nexalis Therapeutics Limited (ASX:NX1) news
Nexalis Therapeutics Limited news releases on 6ix. Latest, Jun 7, 2023: First Patient Dosed for Phase 1, Pain Indication IRX211
Press releases — page 2
First Patient Dosed for Phase 1, Pain Indication IRX211
June 7, 2023
Ethics Approval for Phase 1 CRPS
March 20, 2023
Contract Research Organisation Appointment
December 21, 2022
Board and Management Changes
September 27, 2022
Private Placement to raise $1.2m
September 19, 2022
InhaleRx Ltd appoints Executive Director
December 28, 2021
Appendix 4C Cash Flow Report
October 31, 2021
Quarter 2 Update
July 28, 2021
Appendix 4C - quarterly
July 28, 2021
Quarter 1 Update
April 28, 2021
Quarter 4 Update
January 28, 2021
Placement of Rights Issue Shortfall
January 18, 2021
Rights Issue Offer Document
December 6, 2020
Non-renounceable rights issue
December 6, 2020
$720,500 Private Placement
November 4, 2020
Quarter 3 Update
October 20, 2020
Pause in Trading
October 19, 2020
CEO appointment
October 11, 2020
Reinstatement to Official Quotation
October 1, 2020
Private Placement and Market update
October 1, 2020
Voluntary Suspension
September 28, 2020
Private Placement Successfully Completed to raise $300,000
June 17, 2020
Licence Agreement with Jayex Healthcare
June 11, 2020
Response to ASX Price Query
March 27, 2020
Pause in trading
March 26, 2020
Private Placement Successfully Completed to raise $330,000
January 27, 2020
PRODUCTION OF NEW SLIM LINE SMART VAPORISER FOR USA
December 23, 2019
LIFESPOT SIGNS HEADS OF AGREEMENT WITH IONIC BRANDS
July 1, 2019
Business Development focus in rapid growth Cannabis Category
April 7, 2019
Amended - Appendix 4C September 2018 Quarter
January 31, 2019
Commercial Sales and Distribution Agreement with CBDS Health
December 18, 2018
First production completed for strong vape segment growth
December 12, 2018
LSH Acquires Seng Vital for Cannabis Opportunities
October 1, 2018
Lifespot Strengthens Go-To-Market Cannabis Strategy
September 18, 2018
Update on Unique Cannabis Vaporiser launch and Bodytel
August 16, 2018
LSH in discussions to finance integrated cannabis producers
June 19, 2018
B.Braun to launch Omnitest 5 BT with Body-Tel
June 4, 2018
Unique cannabis vaporizer under evaluation in Israel
May 13, 2018
Amended Appendix 4C - Cash balance at 31/3 $3.904M
April 30, 2018
Update on development of unique cannabis vaporizer
April 13, 2018
New Patient Self-Management System Launched
March 20, 2018
Lifespot Health restructures its Business and Board
November 1, 2017
Lifespot Signs Global Agreement With Beurer
September 7, 2017
Digital Health Consortium Formed To Target $3.5B Market
July 28, 2017
Business & Operational Update
May 18, 2017
LSH enters $50Bn Global Medicinal Cannabis market
May 1, 2017
Update on Medicinal Cannabis opportunities
April 4, 2017
Exploring opportunities in Medicinal Cannabis
March 27, 2017
Lifespot Health wins major contract & strategic b2b partner
March 7, 2017
Lifespot Health to enter coagulation home monitoring market
February 2, 2017